RAPP Annual D&A
$112.00 K
0.00%
31 December 2023
Summary:
As of January 22, 2025, RAPP annual depreciation & amortization is $112.00 thousandRAPP annual D&A is now at all-time high.RAPP Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RAPP Quarterly D&A
$219.00 K
+$11.00 K+5.29%
30 September 2024
Summary:
As of January 22, 2025, RAPP quarterly depreciation & amortization is $219.00 thousand, with the most recent change of +$11.00 thousand (+5.29%) on September 30, 2024. Over the past year, it has increased by +$67.00 thousand (+44.08%). RAPP quarterly D&A is now at all-time high.RAPP Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RAPP TTM D&A
$632.00 K
+$196.00 K+44.95%
30 September 2024
Summary:
As of January 22, 2025, RAPP TTM depreciation & amortization is $632.00 thousand, with the most recent change of +$196.00 thousand (+44.95%) on September 30, 2024. Over the past year, it has increased by +$383.00 thousand (+153.82%). RAPP TTM D&A is now at all-time high.RAPP TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RAPP Depreciation And Amortization Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | +44.1% | +153.8% |
3 y3 years | - | +1360.0% | +4113.3% |
5 y5 years | - | +1360.0% | +4113.3% |
RAPP Depreciation And Amortization High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | at low | at high | +1360.0% | at high | +4113.3% |
5 y | 5-year | at high | at low | at high | +1360.0% | at high | +4113.3% |
alltime | all time | at high | at low | at high | +1360.0% | at high | +4113.3% |
Rapport Therapeutics Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $219.00 K(+5.3%) | $632.00 K(+45.0%) |
June 2024 | - | $208.00 K(+36.8%) | $436.00 K(+75.1%) |
Mar 2024 | - | $152.00 K(+186.8%) | $249.00 K(+122.3%) |
Dec 2023 | $112.00 K | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | - | $53.00 K(+130.4%) | $112.00 K(+89.8%) |
Sept 2023 | - | $23.00 K(+9.5%) | $59.00 K(+63.9%) |
June 2023 | - | $21.00 K(+40.0%) | $36.00 K(+140.0%) |
Mar 2023 | - | $15.00 K | $15.00 K |
FAQ
- What is Rapport Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Rapport Therapeutics?
- What is Rapport Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Rapport Therapeutics?
- What is Rapport Therapeutics quarterly D&A year-on-year change?
- What is Rapport Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Rapport Therapeutics?
- What is Rapport Therapeutics TTM D&A year-on-year change?
What is Rapport Therapeutics annual depreciation & amortization?
The current annual D&A of RAPP is $112.00 K
What is the all time high annual D&A for Rapport Therapeutics?
Rapport Therapeutics all-time high annual depreciation & amortization is $112.00 K
What is Rapport Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of RAPP is $219.00 K
What is the all time high quarterly D&A for Rapport Therapeutics?
Rapport Therapeutics all-time high quarterly depreciation & amortization is $219.00 K
What is Rapport Therapeutics quarterly D&A year-on-year change?
Over the past year, RAPP quarterly depreciation & amortization has changed by +$67.00 K (+44.08%)
What is Rapport Therapeutics TTM depreciation & amortization?
The current TTM D&A of RAPP is $632.00 K
What is the all time high TTM D&A for Rapport Therapeutics?
Rapport Therapeutics all-time high TTM depreciation & amortization is $632.00 K
What is Rapport Therapeutics TTM D&A year-on-year change?
Over the past year, RAPP TTM depreciation & amortization has changed by +$383.00 K (+153.82%)